These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. New small molecule immunosuppressants for transplantation: review of essential concepts. Morris RE J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752 [TBL] [Abstract][Full Text] [Related]
7. New advances in antirejection therapy. Chan M; Pearson GJ Curr Opin Cardiol; 2007 Mar; 22(2):117-22. PubMed ID: 17284990 [TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive drugs and renal transplantation]. Stallone G; Infante B; Gesualdo L G Ital Nefrol; 2005; 22 Suppl 33():S76-9. PubMed ID: 16419011 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Brazelton TR; Morris RE Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine. Smak Gregoor PJ; van Gelder T; Weimar W Neth J Med; 2000 Dec; 57(6):233-46. PubMed ID: 11099793 [TBL] [Abstract][Full Text] [Related]
12. Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection. Simmons WD; Rayhill SC; Sollinger HW Drug Saf; 1997 Aug; 17(2):75-92. PubMed ID: 9285199 [TBL] [Abstract][Full Text] [Related]
13. [Mycophenolate mofetil, a possible new immunosuppresant]. Weberová J; Voboril R; Semecký V Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919 [TBL] [Abstract][Full Text] [Related]
14. Newer immunosuppressive drugs: a review. Gummert JF; Ikonen T; Morris RE J Am Soc Nephrol; 1999 Jun; 10(6):1366-80. PubMed ID: 10361877 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of the alkaloid sinomenine in combination with the immunosuppressive drugs tacrolimus and mycophenolic acid. Vieregge B; Resch K; Kaever V Planta Med; 1999 Feb; 65(1):80-2. PubMed ID: 10083851 [TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive therapy in children. Prasad R; Singh UK; Mittal R; Mishra OP J Indian Med Assoc; 2011 Feb; 109(2):101-2, 104-7. PubMed ID: 21888174 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent]. Yashima Y; Ohgane T Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304 [TBL] [Abstract][Full Text] [Related]
18. Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures. Oliveira VD; Zankl H; Rath T Exp Clin Transplant; 2004 Dec; 2(2):273-9. PubMed ID: 15859941 [TBL] [Abstract][Full Text] [Related]
19. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro. Rumberger B; Kreutz C; Nickel C; Klein M; Lagoutte S; Teschner S; Timmer J; Gerke P; Walz G; Donauer J Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):283-92. PubMed ID: 19235537 [TBL] [Abstract][Full Text] [Related]
20. Prevention of transplant rejection: current treatment guidelines and future developments. Perico N; Remuzzi G Drugs; 1997 Oct; 54(4):533-70. PubMed ID: 9339960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]